Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Minson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|November 7, 2025
Bispecific antibody combination therapies in diffuse large B-cell lymphomaSean Harrop, Adrian Minson, Thiago M Steiner, et al.
Resuscitation|June 29, 2016
A comparison of therapeutic hypothermia and strict therapeutic normothermia after cardiac arrestAndrew Casamento, Adrian Minson, Samuel Radford, et al.
Cancer Nursing|November 27, 2024
Preparing Nurses for CD20-CD3 Bispecific Antibody Treatment in Patients With Non-Hodgkin Lymphoma: A Scoping Review of Adverse Events and Management Strategies From Early Phase and Pivotal TrialsSam van der Linde, Emily Knights, Molly Robertson, et al.
Pathology|March 9, 2021
CAR-T cell therapy: practical guide to routine laboratory monitoringAdrian G Selim, Adrian Minson, Piers Blombery, et al.
Leukemia & Lymphoma|August 16, 2021
Response to everolimus in a patient with refractory HGBL-NOS harboring multiple genomic aberrations in PTENImogen Caldwell, David Byrne, Stephen Lade, et al.
British Journal of Haematology|March 20, 2025
Enterocolitis associated with glofitamab-First report and clinicopathological findings in three casesSean McKeague, Molly Robertson, Sam van der Linde, et al.
The Lancet. Haematology|February 1, 2023
Treatment approaches for patients with TP53-mutated mantle cell lymphomaThomas E Lew, Adrian Minson, Michael Dickinson, et al.
Leukemia & Lymphoma|January 15, 2025
Routine magnetic resonance central nervous system imaging may be avoided in high-risk systemic diffuse large B-cell lymphoma with negative cerebrospinal fluid analysesRory Bennett, Manu Juneja, Mary Ann Anderson, et al.
Leukemia & Lymphoma|April 21, 2026
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphomaBelinda A Campbell, Adrian Minson, Rachel J Brown, et al.
Haematologica|March 21, 2024
Systemic diffuse large B-cell lymphoma involving the central nervous system has high rates of defective antigen presentation and immune surveillanceJoel Wight, Piers Blombery, Jennifer Lickiss, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|November 7, 2025
Bispecific antibody combination therapies in diffuse large B-cell lymphomaSean Harrop, Adrian Minson, Thiago M Steiner, et al.
Resuscitation|June 29, 2016
A comparison of therapeutic hypothermia and strict therapeutic normothermia after cardiac arrestAndrew Casamento, Adrian Minson, Samuel Radford, et al.
Cancer Nursing|November 27, 2024
Preparing Nurses for CD20-CD3 Bispecific Antibody Treatment in Patients With Non-Hodgkin Lymphoma: A Scoping Review of Adverse Events and Management Strategies From Early Phase and Pivotal TrialsSam van der Linde, Emily Knights, Molly Robertson, et al.
Pathology|March 9, 2021
CAR-T cell therapy: practical guide to routine laboratory monitoringAdrian G Selim, Adrian Minson, Piers Blombery, et al.
Leukemia & Lymphoma|August 16, 2021
Response to everolimus in a patient with refractory HGBL-NOS harboring multiple genomic aberrations in PTENImogen Caldwell, David Byrne, Stephen Lade, et al.
British Journal of Haematology|March 20, 2025
Enterocolitis associated with glofitamab-First report and clinicopathological findings in three casesSean McKeague, Molly Robertson, Sam van der Linde, et al.
The Lancet. Haematology|February 1, 2023
Treatment approaches for patients with TP53-mutated mantle cell lymphomaThomas E Lew, Adrian Minson, Michael Dickinson, et al.
Leukemia & Lymphoma|January 15, 2025
Routine magnetic resonance central nervous system imaging may be avoided in high-risk systemic diffuse large B-cell lymphoma with negative cerebrospinal fluid analysesRory Bennett, Manu Juneja, Mary Ann Anderson, et al.
Leukemia & Lymphoma|April 21, 2026
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphomaBelinda A Campbell, Adrian Minson, Rachel J Brown, et al.
Haematologica|March 21, 2024
Systemic diffuse large B-cell lymphoma involving the central nervous system has high rates of defective antigen presentation and immune surveillanceJoel Wight, Piers Blombery, Jennifer Lickiss, et al.
Pageof 3